Delivery Method: VIA UNITED PARCEL SERVICE AND VIA E-MAIL Reference #: 25-HFD-45-01-01 Product: Drugs Recipient: Americo F. Padilla, M.D./Miami Dade Medical Research Institute 8955 Southwest 87th […]

Summary Company Announcement Date: January 24, 2025 FDA Publish Date: January 24, 2025 Product Type: Drugs Reason for Announcement: Recall Reason Description Device & Drug Safety […]

The U.S. Food and Drug Administration (FDA) is providing this communication to increase awareness of recent updates to the product labeling of capecitabine and fluorouracil (5-FU) […]

[Posted 01/22/2025] AUDIENCE: Patient, Caregiver, Health Care Professional, Pharmacy, Neurology ISSUE: The FDA is warning about the risk of a rare but serious allergic reaction with […]

NCTR’s annual report summarizes the key accomplishments for each research division for the reported year. The report includes ongoing research project information, research collaboration highlights, and […]

Choose one of the following roles and start your interview: Pharmaceutical Scientist Physician Regulatory Health Project Manager Don’t see a role you are interested in? Submit […]

Welcome! You want to make a difference. FDA wants to hire you. The FDA Center for Drug Evaluation and Research (CDER) recruits candidates for open positions […]

As part of the Current Good Manufacturing Practice (CGMP) initiative announced in August of 2002, and to help FDA be more transparent with CGMP policy, we […]

1. Why are expiration dates important for consumers to pay attention to? Drug expiration dates reflect the time period during which the product is known to remain […]